GastroenterologyRheumatology

REMICADE

REMICADE (infliximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Crohn’s Disease, Ulcerative Colitis (UC), Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis, Rheumatoid Arthritis, Plaque Psoriasis
Prescribed by Rheumatologists, Gastroenterologists & Dermatologists
How it’s administered Intravenous (IV) infusion
Frequency Three times in the first six weeks, then every eight weeks
Length of treatment About two hours

About This Therapy

REMICADE (infliximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically, it is a tumor necrosis factor (TNF) blocker used for many chronic inflammatory conditions.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

REMICADE REFERRAL FORM

REMICADE REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for REMICADE

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.